Amy Hopkins, NP
Adult Health · Greenville, NCNPI 1861799074
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $24,523 of the $31,374 with a category attached, or 78.2%. AbbVie accounts for 84.7% of it on its own, with 37 other manufacturers making up the rest. Reporting peaked in 2021 at $16,836 and has fallen 90.6% since, to $1,590 in 2025. Among adult health clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 374 payments — averaging $83.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$27K
- Medtronic$996
- Amgen$405
- Boston Scientific$328
- Collegium Pharmaceutical, Inc.$320
- Teva Pharmaceuticals USA, Inc.$299
- plus $2K from 32 others
What the payments were for
- Speaking & faculty fees$24,52378%
- Travel & lodging$5922%
- Food & beverage$6,11619%
- Education$1440%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 121 | $26,563 |
| Medtronic | 42 | $996 |
| Amgen | 31 | $405 |
| Boston Scientific | 6 | $328 |
| Collegium Pharmaceutical, Inc. | 16 | $320 |
| Teva Pharmaceuticals USA, Inc. | 20 | $299 |
| Pfizer | 13 | $268 |
| Globus Medical | 2 | $255 |
| Sanofi | 13 | $208 |
| Novartis | 9 | $149 |
| Biohaven Pharmaceuticals, Inc. | 15 | $147 |
| Amneal Pharmaceuticals LLC | 9 | $141 |
| Biohaven Pharmaceutical Holding Company Ltd. | 9 | $128 |
| Supernus Pharmaceuticals, Inc. | 10 | $127 |
| Johnson & Johnson | 2 | $114 |
| Avanir Pharmaceuticals, Inc. | 7 | $110 |
| Upsher-smith Laboratories LLC | 5 | $90 |
| Bristol Myers Squibb | 4 | $69 |
| Avion Pharmaceuticals | 4 | $69 |
| SPR Therapeutics, Inc | 3 | $66 |
| Lundbeck LLC | 3 | $56 |
| Sunovion Pharmaceuticals Inc. | 4 | $49 |
| Merz Pharmaceuticals, LLC | 3 | $49 |
| Lilly USA, LLC | 3 | $45 |
| MDD US Operations, LLC | 3 | $41 |
| Neurocrine Biosciences, Inc. | 2 | $38 |
| UCB, Inc. | 2 | $34 |
| Biogen | 2 | $32 |
| Virtus Pharmaceuticals LLC | 2 | $32 |
| Saluda Medical Americas, Inc. | 1 | $26 |
| Scilex Pharmaceuticals Inc. | 1 | $22 |
| Merck | 1 | $17 |
| EMD Serono, Inc. | 1 | $17 |
| Vertos Medical, Inc. | 1 | $17 |
| Adamas Pharmaceuticals, Inc. | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Almatica Pharma LLC | 1 | $12 |
| Currax Pharmaceuticals LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$23,069
- QULIPTA$2,178
- INCEPTIV$232
- Senza$206
- INTELLIS ADAPTIVESTIM$146
- BOTOX$125
- WaveWriter Alpha Prime 16$117
- Intracept$109
- NURTEC ODT$100
How this compares
$31,374 in reported general payments places this provider in the 95th percentile of 614 adult health providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 192 | $44,787 |
| BelbucaBuprenorphine Hcl | 53 | $37,839 |
| Xtampza ErOxycodone Myristate | 40 | $29,152 |
| Trokendi XrTopiramate | 21 | $26,590 |
| NucyntaTapentadol Hcl | 24 | $20,263 |
| Nucynta ErTapentadol Hcl | 16 | $18,434 |
| UbrelvyUbrogepant | 13 | $17,132 |
| Oxymorphone Hcl ErOxymorphone Hcl | 14 | $9,949 |
| LinzessLinaclotide | 12 | $6,553 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 265 | $5,372 |
| Pregabalin | 273 | $4,233 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 121 | $2,915 |
| Gabapentin | 194 | $2,759 |
| Lidocaine | 24 | $2,040 |
| Tramadol Hcl | 259 | $1,948 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er, Nucynta, Nucynta Er | $320 | $105,689133 claims |
| Supernus Pharmaceuticals, Inc.Trokendi Xr | $127 | $26,59021 claims |
| AbbVieUbrelvy, Linzess | $26,563 | $23,68525 claims |
| Upsher-smith Laboratories LLCTopiramate | $90 | $7815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 614 adult health providers in North Carolina.
Other adult health in Greenville
- Felicia RichardsonGreenville$64K
- Lakeisha GreenfieldGreenville$15K
- Veronica PriceGreenville$10K
- Heather LarsenGreenville$9K
- Steffani LetchworthGreenville$8K
- Amanda StanfordGreenville$5K
- Robert DodgeRaleigh$311K
- Kimberly CampDurham$147K
- Henry VanpalaRaleigh$110K
- Jolene SpencerWashington$83K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.